Source disclosure: February 04, 2026
Astellas Pharma Inc. [4503.T]
TOKYO, Feb 17 (Pulse News Wire) – Astellas Pharma Inc. (4503.T) reported consolidated results for Q3 FY2026 (ending March 2026).
2% YoY).
For the next fiscal year, the company forecasts 8%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms • Original filing💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.